(Q44017725)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23161460%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

title

Disease reactivation after fingolimod discontinuation in two multiple sclerosis patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23161460%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23161460%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Pietro Annovazzi

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23161460%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Massimo Filippi

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23161460%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

1

A Ghezzi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23161460%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

author name string

D Baroncini

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23161460%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

M Zaffaroni

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23161460%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

G Minonzio

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23161460%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

G Comi

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23161460%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

publication date

16 November 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23161460%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23161460%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

volume

260

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23161460%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23161460%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

page(s)

327-329

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23161460%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00415-012-6744-7

18 February 2020

exact match

0 references

cites work

Rebound of disease activity after withdrawal of fingolimod (FTY720) treatment

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6744-7

Withdrawal of fingolimod treatment for relapsing-remitting multiple sclerosis: report of six cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6744-7

Multiple sclerosis rebound following herpes zoster infection and suspension of fingolimod.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6744-7

A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6744-7

Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6744-7

Secondary progressive multiple sclerosis: current knowledge and future challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6744-7

Prevention of experimental autoimmune encephalomyelitis by antibodies against alpha 4 beta 1 integrin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6744-7

Fingolimod in multiple sclerosis: mechanisms of action and clinical efficacy

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23161460

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Immune reconstitution inflammatory syndrome in patients with multiple sclerosis following cessation of natalizumab therapy

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23161460

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S00415-012-6744-7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23161460%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

1 reference